| Trial registration number
|
NCT04823351 |
Full text link
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04823351
|
First author
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Michel Bielecki, MD
|
Contact
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
michel.bielecki@uzh.ch
|
Registration date
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-03-30
|
Recruitment status
Last imported at : March 14, 2023, midnight
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Crossover
|
Masking
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
study inclusion criteria;
- written informed consent
- healthcare workers at nursing homes with resident contact
- willingness to adhere to study protocol
additional inclusion criteria for primary objective 2 (reinfection after vaccination)
- sars-cov-2 vaccination
list the study
|
Exclusion criteria
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
- unwillingness to adhere to study protocol
- hcw exclusively working with patients with aerosol-generating procedures during the
entire study period
|
Number of arms
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
University of Zurich
|
Inclusion age min
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
65
|
Countries
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Switzerland
|
Type of patients
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Health workers
|
Severity scale
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
1200
|
primary outcome
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
SARS-CoV-2 infection
|
Notes
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : April 1, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": " ", "treatment_id": 509, "treatment_name": "Ffp2 mask", "treatment_type": "Protective device", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": " ", "treatment_id": 1250, "treatment_name": "Surgical facial mask", "treatment_type": "Protective device", "pharmacological_treatment": "Non pharmacological treatment"}]
|